Literature DB >> 7544298

A novel beta 1 integrin isoform produced by alternative splicing: unique expression in cardiac and skeletal muscle.

A van der Flier1, I Kuikman, C Baudoin, R van der Neut, A Sonnenberg.   

Abstract

The mRNA's of several integrin subunits are alternatively spliced in the region encoding cytoplasmic domains, that may potentially provide alternative integrin-cytoskeleton interactions and transmembrane signaling pathways. We identified a novel cytoplasmic tail variant of the human beta 1 subunit by reverse transcriptase polymerase chain reaction. This fourth beta 1 variant, named beta 1D, is specific for skeletal and cardiac muscle. The determined genomic organization of the 3'-region of the human beta 1 gene reveals that beta 1D is produced by alternative splicing of mRNA. In addition, we show that the expression of beta 1D is developmentally regulated during murine myoblast differentiation, suggesting a role for beta 1D in myogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544298     DOI: 10.1016/0014-5793(95)00814-p

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Impaired axonal regeneration in alpha7 integrin-deficient mice.

Authors:  A Werner; M Willem; L L Jones; G W Kreutzberg; U Mayer; G Raivich
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

2.  Expression of alpha7beta1 integrin splicing variants during skeletal muscle regeneration.

Authors:  Minna Kääriäinen; Liisa Nissinen; Stephen Kaufman; Arnoud Sonnenberg; Markku Järvinen; Jyrki Heino; Hannu Kalimo
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

3.  The beta1 cytoplasmic domain regulates the laminin-binding specificity of the alpha7X1 integrin.

Authors:  Ming-Guang Yeh; Barry L Ziober; Baomei Liu; Galina Lipkina; Ioannis S Vizirianakis; Randall H Kramer
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

4.  Identification of beta1C-2, a novel variant of the integrin beta1 subunit generated by utilization of an alternative splice acceptor site in exon C.

Authors:  G Svineng; R Fässler; S Johansson
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

5.  Knockout and knockin of the beta1 exon D define distinct roles for integrin splice variants in heart function and embryonic development.

Authors:  C Baudoin; M J Goumans; C Mummery; A Sonnenberg
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

6.  The laminin-binding activity of the alpha 7 integrin receptor is defined by developmentally regulated splicing in the extracellular domain.

Authors:  B L Ziober; Y Chen; R H Kramer
Journal:  Mol Biol Cell       Date:  1997-09       Impact factor: 4.138

Review 7.  Integrin signaling: linking mechanical stimulation to skeletal muscle hypertrophy.

Authors:  Marni D Boppart; Ziad S Mahmassani
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-17       Impact factor: 4.249

8.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

9.  Evidence for skeletal muscle fiber type-specific expressions of mechanosensors.

Authors:  Sebastian Mathes; Mathias Vanmunster; Wilhelm Bloch; Frank Suhr
Journal:  Cell Mol Life Sci       Date:  2019-01-30       Impact factor: 9.261

10.  Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion.

Authors:  Navaline L Quach; Stefano Biressi; Louis F Reichardt; Charles Keller; Thomas A Rando
Journal:  Mol Biol Cell       Date:  2009-05-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.